Lexicon Pharmaceuticals LXRX Other operating expenses
Other operating expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherExpenses.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's other operating expenses?
- Lexicon Pharmaceuticals (LXRX) reported other operating expenses of $1.59M in Q1 2026.
- How has Lexicon Pharmaceuticals's other operating expenses changed year-over-year?
- Lexicon Pharmaceuticals's other operating expenses decreased by 13.4% year-over-year, from $1.84M to $1.59M.
- What is the long-term trend for Lexicon Pharmaceuticals's other operating expenses?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's other operating expenses has grown at a -44.4% compound annual growth rate (CAGR), from $87.39M to $8.34M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.